IC 302-2022: Hype, Promise, and Reality: Orthopedic Use of Biologics in 2022-Hype, Promise, and Reality: Orthopedic Use of Biologics in 2022 (3/5)

Video Transcription

Video Summary

The video, delivered as a presentation, focuses on biologics and their application in treating osteoarthritis and cartilage defects. The speaker discusses the different types of biologics and their uses, with an emphasis on platelet-rich plasma (PRP) and adipose-derived cells. They address the role of inflammation in osteoarthritis and the potential benefits of using biologics to target this inflammatory component. The speaker also highlights the importance of choosing the right patients for biologics treatment based on their specific symptoms and conditions.<br /><br />Throughout the presentation, the speaker references scientific studies and clinical trials to support their statements. They emphasize the need for further research and clinical trials to fully understand the efficacy of biologics. They also discuss the various techniques for harvesting and processing adipose-derived cells, as well as their application in cartilage regeneration.<br /><br />The speaker mentions the potential of subchondral bone treatment using biologics and the importance of considering the overall joint environment when evaluating the effectiveness of biologics. They touch on the concept of targeted therapy in biologics and the ongoing development of more specific treatments based on individual etiologies.<br /><br />Overall, the presentation provides an overview of biologics and their potential applications in treating osteoarthritis and cartilage defects, highlighting the current state of research and the need for further study.

Asset Caption

Jason Dragoo, MD

Keywords

biologics

osteaoarthritis treatment

cartilage defects

platelet-rich plasma

adipose-derived cells

inflammation

clinical trials